Who runs the healthcare world? Women make 80% of all buying decisions and make up over 70% of the healthcare workforce—yet in 2020 we still do not have an equal voice in the ranks of leadership. Diversity is also an issue when it comes to venture capital. Female entrepreneurs continue to struggle to raise as [….]
Developing medication, devices, and products for children is not a matter of “shrinking” down the adult version. Delivering solutions to our littlest patients requires a long-term approach that deliberately centers children in all stages of innovation – from ideation to incubation, from clinical trials to market. Join Chief Innovation Officer of Children’s National Health System [….]
6 People in the BioHealth Capital Region You Should Know In 2020 2019 was a year of change for many BioHealth Capital Region organizations. The past year has seen a host of notable leadership transitions that are sure to have an impact in the region. The Maryland Department of Commerce said goodbye to Secretary Mike [….]
Antimicrobial resistance (AMR) is in the news lately and for good reason. Diseases that were once easy to treat are becoming increasingly difficult to cure. But the largest contributor to AMR is a disease that rarely makes headlines – drug-resistant tuberculosis (DR-TB), the world’s only airborne drug-resistant infection. DR-TB makes up a third of the [….]
Representatives from Johnson & Johnson Innovation will provide an overview of goals and mission, highlighting how Johnson & Johnson Innovation interacts with the entrepreneurial community through JLABS, JJDC, The Innovation Centers and Janssen Business & Development.
The new Children’s National Innovation Campus with JLABS-DC, part of the Walter Reed Redevelopment project in NW Washington DC.
2019 BioHealth Capital Region Forum Insights and Key Takeaways April 10, 2019 The 5th annual Biohealth Capital Region (BHCR) Forum was held on April 8th and 9th at AstraZeneca in Gaithersburg, MD. Biotech and life science executives and expert speakers from industry, academia, healthcare, government, finance and real estate development, among others, converged to discuss [….]
